|
According to a new study published this week in Breast Cancer Research,
daily aspirin use appears to slightly reduce the risk of estrogen
receptor-positive (ER+) breast cancer, the most common type of breast
cancer. However, the current evidence isn't strong enough to suggest
women take aspirin as a preventative measure, and experts caution
against regular use of the painkiller for this purpose, warning it can
cause serious gastrointestinal bleeding.
Numerous studies have looked at whether aspirin and other
non-steroidal anti-inflammatory drugs (NSAIDs) reduce breast cancer
risk, but the findings have been inconsistent. Some research has shown
that the drugs have a protective effect, while other studies have found
no association. A few studies have even linked NSAIDs with an increased
cancer risk.
"On the whole, these studies have not provided convincing
evidence that using either aspirin or other NSAIDs can reduce breast
cancer risk," according to Eric Jacobs, PhD, American Cancer Society,
strategic director, pharmacoepidemiology. "Further research is needed
before any conclusions can be made."
This particular study was based on data from the National
Institutes of Health—AARP Diet and Health Study, a questionnaire-based
analysis of diet, health habits, and cancer incidence of AARP members
during 1996-1997. The researchers, led by the National Cancer
Institute's Gretchen Gierach, MPH, PhD, looked at data on breast cancer
incidence and NSAID use among 127,383 mostly white, post-menopausal
women aged 51 to 72 who were enrolled in the study.
The team found no significant association between NSAID use
and breast cancer risk, but when they looked more closely at
associations between specific types of NSAIDs and breast cancer tumor
characteristics, they found a 16% reduction in ER-positive breast
cancer risk with daily aspirin use. No association was found between
NSAID use (aspirin or otherwise) and ER-negative breast cancer.
(ER-negative breast cancer accounts for approximately 25% of the cases
seen in the US.)
NSAIDs inhibit the enzyme cyclooxygenase, which could play a
role in disrupting breast cancer growth by suppressing estrogen
synthesis. Aspirin is unique among NSAIDs: it irreversibly inhibits
cyclooxygenase, which could explain its possibly preventive role.
However, scientists are still investigating these processes. In the
meantime, experts warn against raiding your medicine cabinet in the
hopes of warding off cancer.
"The American Cancer Society does not recommend using aspirin
for cancer prevention because aspirin can cause serious
gastrointestinal bleeding. Whether or not a person should use aspirin
for disease prevention is a question that should be discussed with
their doctor who can take their medical history into account," says
Jacobs. "This decision should be based on balancing the proven benefits
of aspirin in preventing heart disease against the proven risks of
serious gastrointestinal bleeding."
Although there is no sure-fire way to prevent breast cancer,
there are things women can do to reduce their risk. Avoiding alcohol,
exercising regularly, and maintaining a healthy body weight can all
help lower risk.
For women at high risk for breast cancer, medicines such as
tamoxifen or raloxifene might be options. For more information, see Medicines
to Reduce Breast Cancer Risk.
One of the best ways to protect your health is to get a
regular mammogram, which can find breast cancer at its earliest stages,
when it is easier to treat. The American Cancer Society recommends
every woman aged 40 and over schedule a yearly screening mammogram. For
more information, see "Can Breast Cancer Be Found Early?," Mammograms
and Other Breast Imaging Procedures, and Mammograms Matter.
ACS News Center stories are provided as a source of cancer-related
news and are not intended to be used as
press releases.
|